Replies to post #652 on Momenta Pharmaceuticals, Inc. (MNTA)

[HattieTheWitch]

1. 8 Nov WSJ article:
(Teva PR) met in Oct with FDA - "application stuck in bureaucratic limbo"

2. 2 Nov Teva earnings call:
(BM)"On the enoxaparin, there isn't a whole lot more color to add to enoxaparin other than what I think is important is we achieved chemical sameness and we're in review with OPD, and meeting with management helped us feel much better about the situation... I'd be deeply disappointed if we didn't get the approval yet this year, but again we can't be certain."

So, they're feeling much better about the situation: the situation being that they're stuck in bureaucratic limbo, right?

Uh huh.